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CHAPTER I 
 
INTRODUCTION 
 
Motivation 
 
To determine the genetic etiology of disease, we must understand the functional effects of 
disease-causing genetic variants. Causal variants that alter amino acids in the protein-coding 
sequences of genes (i.e., missense variants) are believed to predominantly derive their 
pathogenicity from the alteration of protein structure, and consequently, protein function. 
Through evolutionary and molecular analyses, we know that functionality is not distributed 
evenly throughout a protein. Few amino acids in a protein structure compose active sites or 
binding interfaces; most amino acids are responsible for protein folding and stability. The 
mechanism by which a missense variant does or does not disrupt protein function is dependent 
on the part of the protein it affects and the degree to which the specific amino acid substitution 
affects it. While the specific function of many proteins is not always well characterized, 
evolutionary conservation analyses can identify which amino acids in a protein have been highly 
conserved across species, indicating functional importance. Initial evidence from a small number 
of proteins suggests that these evolutionarily conserved amino acids are spatially clustered within 
protein structures. If this pattern holds for all proteins, the spatial analysis of evolutionarily 
conserved amino acids in protein structure has the potential to accurately resolve regions of 
functional importance. While sequence conservation highlights the importance of some amino 
acids, clear spatial boundaries can inform functional hypotheses about why they are important. 
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If functionally important residues are spatially clustered, we hypothesize that functionally 
disruptive, disease-causing missense variants will also be spatially clustered. While evolutionary 
conservation may identify amino acids (or regions) of functional importance, it provides no 
information about what function is being performed. Disease-causing variation can often infer 
the functional role of a region from the phenotypic outcome of its disruption. With the recent 
abundance of whole-genome and whole-exome sequencing data, coupled with growing numbers 
of experimentally derived and computationally predicted protein structures, we have an 
opportunity to investigate these patterns on the scale of the human proteome. 
 
Evidence for Conserved Amino Acid Clustering in Protein Structure 
 
Identifying functional regions of protein structures is currently difficult, as our understanding of 
protein function is incomplete. Computational modeling and prediction is steadily improving 
with the advent of methods like ddg_monomer1 and VIPUR2, but at present we cannot reliably 
predict (in an accurate, high-throughput manner) the structural impact of amino acid 
substitutions or how the resulting structural changes will ultimately influence function without 
expert analysis. While it is sometimes possible to empirically determine the functional effect of a 
given substitution, such assays are inherently low-throughput and limited to proteins for which a 
functional assay is available. Sequence conservation can help to bridge this gap by identifying 
amino acids that have been highly conserved throughout evolution, suggesting they play an 
important role in the function or stability of that protein.  
This measure of functional importance has motivated several efforts towards the analysis of 
evolutionary conservation in protein structure. ConSurf-DB3 was designed to identify and 
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visualize the most and least conserved amino acids in a protein structure, independent from the 
protein’s baseline degree of conservation. Capra et al. found that the combination of 
evolutionary sequence conservation and protein structure significantly improved detection of 
ligand-binding sites over both conservation-only and structure-only methods.4 Madabushi et al.5 
more directly evaluated the spatial clustering hypothesis, calculating Evolutionary Trace6 for 
each amino acid in 46 proteins from different structural and functional classes. They found that 
conserved amino acid clusters were significantly larger than expected (relative to a random 
distribution) in 45 of the 46 proteins analyzed. The utility of this spatial clustering pattern has 
also been recognized in the field of protein fold prediction. Baker et al. 7 identified significant 
clustering of conserved residues in 73 of 79 analyzed protein structures. They then demonstrated 
that algorithmic constraints requiring conserved residues to be in close spatial proximity 
dramatically improve de novo protein structure prediction. Other structural analyses of 
evolutionary conservation include the identification of conserved positions in protein folds,8 
binding interfaces,9 and the prediction of functional sites.10–13 Each of these analyses is limited in 
either scope or scale, but the consistency of their findings supports the hypothesis that 
evolutionarily conserved residues cluster in protein structures and that those clusters represent 
functional regions of proteins. 
 
Evolutionary Conservation is Predictive of Variant Pathogenicity 
 
Disease-causing missense variants are presumed to derive their pathogenicity from the disruption 
of protein function and stability. As discussed above, functional amino acids can be identified 
through evolutionary conservation analysis. It follows that missense variants affecting 
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evolutionarily conserved amino acids are more likely to disrupt protein function. Application of 
this hypothesis has been overwhelmingly successful in variant pathogenicity prediction. All nine 
of the popular pathogenicity prediction algorithms evaluated by Thusberg et al.14 incorporate 
some measure of evolutionary conservation15–22.  
 
Mendelian Germline Variants and Recurrent Somatic Mutations Cluster in Protein Structure 
 
The strong evidence for conserved residue clustering and the relationship between evolutionary 
conservation and variant pathogenicity suggests that disease-causing missense variants also form 
clusters in protein structure and that these clusters identify functional regions of proteins with 
relevance to specific diseases. Indeed, the literature already includes initial evidence for the 
pathogenic clustering of Mendelian and somatic cancer mutations. In an analysis of 162 diseases 
affecting 181 genes, Turner et al.23 found that both dominant and recessive disease-causing 
mutations were significantly more clustered than neutral variants from the 1000 Genomes 
Project24. Numerous studies have also analyzed the clustering of somatic mutations in cancer25–
31, where discriminating between driver and passenger mutations is a challenge. Despite 
differences in methodology, all have identified significant clustering of somatic mutations in 
both the sequence and structure of oncogenes, tumor suppressors, and genes not previously 
associated with cancer. These germline and somatic analyses are analogous. Oncogene and 
dominantly inherited mutations are largely presumed to result in gain-of-function, while tumor 
suppressor and recessive mutations are presumed to result in loss-of-function. It is likely that 
these analyses are detecting a similar phenomenon: pathogenic variants in close spatial proximity 
share similar functional and disease-related properties. This phenotypic similarity is highlighted 
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by Guo et al. in their comprehensive analysis of three-dimensional protein interactome networks. 
They found that recessive mutations in interacting proteins were significantly more likely to 
cause the same disease if they affected the binding interface of those two proteins32.   
 
Current Methods for Quantifying Missense Variant Clustering 
 
There is substantial evidence to support the hypothesis that pathogenic variants form spatial 
clusters in protein structure, but the methods for evaluating these distributions are redefined by 
each subsequent publication and are often focused towards the identification of a few known 
examples. In this section I will discuss four methods for quantifying the degree of spatial 
clustering observed for missense variants along with their strengths and weaknesses.  
A straightforward way of evaluating clustering amongst a set of points is the sum of inverse 
pairwise distances. Stehr et al.30 adopted this approach in their analysis of somatic mutations in 
24 oncogenes and tumor suppressors (Figure 1A). Within each protein structure, they calculated 
the sum of inverse pairwise distances amongst somatic mutations from COSMIC33 and 
population-derived missense single-nucleotide polymorphisms (SNPs) from the 1000 Genomes 
Project. They conclude that all missense variants, regardless of pathogenicity, were significantly 
more clustered than expected at random. Moreover, somatic mutations in oncogenes were more 
significantly more clustered than population-derived SNPs, while somatic mutations in tumor 
suppressors were not. Although the sample size is small and limited to known cancer genes, the 
results of this analysis defined expectation for future studies of the spatial distributions of 
somatic mutations. 
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While the sum of inverse pairwise distances is simple to compute, it incorporates no 
information about biologically meaningful distances or the frequency at which a mutation is 
observed in individuals with cancer. Kamburov et al.26 addressed these concerns with the 
introduction the two transformations shown in Figure 1B.  First, each variant is weighted 
according to its frequency using somatic mutation counts from The Cancer Genome Atlas 
(TCGA)34.   The mutation frequency is transformed, such that mutations observed in only one 
individual receive values near 0, while mutations observed in six or more individuals receive a 
value of 1. Each pair-wise distance is then transformed such that highly proximal mutations 
receive values near 1, and distal variants receive values approaching 0. The extent of clustering 
within the protein structure is then scored as the sum of the weighted, pairwise distances between 
recurrence-weighted somatic mutations. Ultimately, proteins with highly recurrent mutations in 
close spatial proximity receive high scores and those containing distal mutations with low 
recurrence receive low scores. The significance of these scores is evaluated by randomly 
permuting the locations of somatic mutations within the protein structure. In their analysis of 
4,062 human proteins, 10 were found to harbor significantly clustered recurrent somatic 
mutations at a false discovery rate (FDR) q<0.1. Unlike Stehr et al., Kamburov et al. observe 
significant clustering in both oncogenes and tumor suppressors, as well as in proteins not 
previously associated with cancer; they attribute this difference largely to methodological 
differences and dataset selection. A weakness of this approach is the reliance on user-intuition in 
defining biologically plausible distances and recurrence counts. Additionally, neither of these 
approaches identify discrete clusters of mutations nor do they define functional boundaries; 
rather, they report that somatic mutations within the protein structure are more clustered than the 
null expectation.  
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In contrast, the approach proposed by Meyer et al.25 aims to define clusters directly and then 
evaluates the significance of the clusters themselves. It accomplishes this with complete-linkage 
hierarchical clustering using the distance between somatic mutations (Figure 1C). Complete-
linkage clustering enforces a maximum distance between any two mutations in the same cluster. 
This distance is user-defined, but a value of 15Å was used for their comprehensive analyses. The 
algorithm additionally enforces the minimum cluster size (number of mutations) of three or more 
unique amino acid substitutions at two or more unique protein positions. Justification of these 
parameters is not provided. The significance of each cluster was determined through random 
permutation of the mutations within the protein structure. Clusters that contained more mutations 
than expected at random were considered significant. Although this approach defines clear 
mutation clusters, there are also several weaknesses. First, many of the algorithm’s parameters 
are user-defined without clear evidence for biologically plausible arguments. Second, many of 
the clusters identified by the algorithm are heavily influenced by highly recurrent mutations at 
only two protein positions. While these recurrent mutations may disrupt the same function, it is 
unlikely that cluster analysis is required to identify their importance.  
Most recently, a novel cluster analysis was reported by Tokheim et al.27 that incorporates 
many of the attributes from the above work. The first stage of this analysis evaluates the local 
missense mutation density around each somatic mutation. This is defined as the sum of the count 
of missense mutations observed at each mutation position and the count of missense mutations 
within 10Å of that site (Figure 1D). A distance threshold of 10Å was chosen because it is the 
order of magnitude of an amino acid side chain27. Permutation of the mutation positions within 
the structure is used to generate an empirical null and determine which mutations are within 
“mutation hotspot regions.” Once identified, these mutations are grouped into clusters using a 
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neighbor graph such that neighbors within 10Å of one another are connected. Each subgraph is 
then defined as a mutation cluster. With this approach, Tokheim et al. can define clusters of 
variable shape and size while still restricting local density measures to a biologically plausible 
scale. However, the method still makes assumptions about what distance scales are biologically 
plausible. Also, because no recurrence normalization was applied to the somatic mutation counts 
(as described in Kamburov et al.) and because the mutation count for a given protein position is 
included in its local mutation density estimate, the method tend to identify individual (or pairs 
of) highly recurrent mutations that are likely identifiable without cluster analysis. 
 
 Figure 1: Methodological illustrations of approaches for identifying missense variant clustering in protein structure. 
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Limitations of Hypothesis-Driven Clustering Methodologies 
 
Each of the methods described above was designed specifically for the identification of 
clusters of somatic mutations, with heavy influence from known examples in cancer. This limits 
the generalizability and applicability of these methods for testing alternative spatial hypotheses. 
Collectively, these methods have several limitations. The first is a reliance on experimenter 
intuition. All but Stehr et al. include intuition-based parameterization: Kamburov et al. transform 
distance and recurrence, Meyer et al. impose an arbitrary upper bound on cluster diameter and 
lower bound on mutation counts within observed clusters, and Tokheim et al. define distance 
bounds for the “local” neighborhood of a mutation that are based on the approximate length of an 
amino acid side chain. Within each study, justification was provided for why these 
normalizations and bounds are necessary, but little justification was provided for their 
parameterization. While it is important that method parameters and results are within 
biologically plausible limits, each of these decisions narrows the types of clusters that can be 
discovered. For example, a major benefit of hierarchical clustering is its ability to detect non-
spherical clusters, but the complete-linkage aggregation and maximum distance threshold used 
by Meyer et al. will lead the algorithm towards small, spherical clusters and cannot accurately 
recognize non-spherical clusters if the longest axis exceeds 15Å. These restrictions limit its 
effectiveness in analyzing transmembrane proteins or protein-protein binding interfaces where 
functional regions may be non-spherical. It is also unclear if parameters inferred from somatic 
mutation clusters will be optimal for other types of genetic variation and structural properties. 
There has been significant, recent interest in identifying genes with significantly less population-
derived missense variation than expected by chance35. Evaluating the regional patterns of this 
 10 
phenomenon within protein structure would require a fundamentally different hypothesis about 
the expected and observed spatial distribution of (putatively neutral) missense variants. Each of 
the methodologies described above would require significant modification to evaluate these new 
hypotheses because they’ve been designed specifically to identify clusters of disease-causing 
variants. 
The second major limitation is the narrow scope of previous work. Most of these analyses 
focus heavily on clusters of somatic mutation in cancer, but the functional properties driving 
missense spatial constraint should be similarly applicable to germline missense variation. Meyer 
et al. briefly discuss an increased likelihood of clustering Human Gene Mutation Database 
(HGMD)36 pathogenic variants relative to putatively benign variants from the Exome Variant 
Server (http://evs.gs.washington.edu/EVS/), but that analysis pools together pathogenic and 
putatively benign variants to simulate the mixture of driver and passenger mutations in cancer. 
Ultimately, the comparison is only discussed as justification for analyzing somatic mutation data. 
Some analyses have instead focused on the spatial clustering observed for evolutionary 
conservation, but these studies have been limited in scale. Despite heavy reliance on the 
conclusions of several small studies, there has not been a comprehensive, systematic evaluation 
of conserved residue clustering across all human proteins. 
Many previous studies have compared the general patterns of clustering observed for somatic 
mutation with the patterns observed for population-derived missense variants, but none provide 
the option of evaluating one dataset in relation to another. For example, Stehr et al. found that 
somatic mutations in tumor suppressors were no more clustered than population-derived 
missense variants. This conclusion was drawn from a comparison of the global trends observed 
for the two datasets. A more direct hypothesis for this comparison would test whether somatic 
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mutations were more or less clustered than population-derived missense variants within each 
structure. This more specific hypothesis may identify specific proteins in which the clustering of 
somatic mutations is significantly more than for population-derived missense variation, in 
contrast to the global trend. 
The methodology for analyzing spatial distributions in protein structure should not be 
influenced by domain-specific hypotheses. A general, data-driven approach is needed that is 
equally capable of analyzing evolutionary and structural properties as well as germline and 
somatic protein-coding variation. This approach should then be applied to the numerous datasets 
of evolutionary, genetic, and structural data publically available to evaluate previously observed 
patterns and novel hypotheses on a comprehensive scale. These data are not independent from 
one another, but are largely influenced by similar biological pressures. This approach should 
enable comparisons between synonymous and missense variants, conserved amino acids and 
pathogenic variants, or germline and somatic variants. In the following chapters, I describe such 
an approach along with a pipeline and database to support the high-throughput, spatial analysis 
of evolutionary conservation and human genetic variation within protein structure. 
 
Chapters 
 
The process of linking genetic variant information to amino acid coordinates in experimentally 
derived protein structures is a non-trivial task involving numerous resources and databases, each 
with their own format, cross-references, and inconsistencies. In chapter 2, I provide a detailed 
description of the PDBMap pipeline and database. The purpose of this resource is the linkage of 
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existing databases of genetic and structural information to facilitate efficient evaluation of 
structural hypotheses about missense variation on a global scale. 
Once missense variants have been placed within protein structure, we require a robust 
statistical framework to quantify their spatial distribution. In chapter 3, I describe a general 
methodology for evaluating spatial distributions within and between datasets of protein-coding 
variation and structural properties. These methods make no assumptions about cluster size, 
shape, or scale, are sensitive to both clustering and dispersion, and are not tailored to find 
domain-specific examples. With this framework, we aim to quantify on a large-scale whether 
evolutionarily conserved amino acids are clustered in protein structures. We next evaluate 
whether spatial patterns of missense variation are derived from the effects of amino acid 
substitution by contrasting synonymous and nonsynonymous distributions. With these properties 
defined, we evaluate the hypotheses that pathogenic missense variants are clustered in protein 
structures and that the degree of clustering exceeds what is observed for neutral variants. Finally, 
we highlight the utility of spatial information by evaluating its predictive performance in 
classifying pathogenic and neutral missense variants.
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CHAPTER II 
 
PDBMAP: MAPPING PROTEIN-CODING VARIATION INTO PROTEIN STRUCTURE 
 
Introduction 
 
Although the processes of gene transcription, mRNA translation, and protein folding are 
biologically linked, the scientific fragmentation of genetics, proteomics, and structural biology 
introduces technical barriers to holistic analysis. These limitations impede large-scale analysis of 
genetic variation in the context of protein structure and complicate the evaluation of otherwise 
testable hypotheses. In this chapter, I present PDBMap, a pipeline and database for explicit 
mapping between the human genome and structome. The initial pipeline pre-computes the 
mapping between all amino acids in all experimentally derived and computationally predicted 
protein structures and all protein-coding nucleotides in the human genome. Using this resource, 
genetic variants and annotations can be directly mapped into all available protein structures 
without navigating the entire cross-reference network. Finally, we populate this database with the 
largest public datasets of protein structures and genetic variation: The Protein Data Bank37 
(27,624 human protein structures), ModBase38 (102,235 human homology models), ExAC35 
(4,521,130 synonymous and missense variants), and ClinVar39 (56,162 missense variants). 
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Protein Structural Databases 
 
The Protein Databank 
The Protein Data Bank (PDB) is the central repository for experimentally derived protein 
structures with over 5,000 distinct human proteins represented by more than 27,000 structures. 
Because of the many-to-many relationship of proteins to structures, there are analyses included 
in this project that limit the dataset to a representative subset of individual protein chains. This 
subset was generated by Kamburov et al.26 and is intended to provide the greatest coverage of 
the human proteome while minimizing redundancy. Although protein structures in the PDB are 
determined by a variety of experimental methods, all those included in this subset were derived 
from either X-ray crystallography or solution NMR. All solution NMR structures were 
represented by the first recorded model. 
 
ModBase 
ModBase is a public repository of comparative protein structure models. Their automated 
pipeline uses the Modeller40 software to generate homology models for the database. Homology 
modeling involves the identification of proteins with high sequence identity to a protein of 
interest, which is likely to adopt a similar tertiary fold. The homologous structure is then used as 
a template along which the sequence of the target protein is threaded. From this starting state, a 
series of loop-building and relaxation processes attempt to identify the lowest energy 
conformation, which is presumed to be the protein’s native state. The quality of computationally 
predicted homology models is highly variable and largely dependent on sequence identity with 
the template structure. Models are evaluated using the ModPipe quality score (MPQS), a 
 15 
composite score incorporating sequence identity of the target protein with the identified template 
structure, structural coverage of the target protein, and three external quality scores: e-value, z-
Dope, and GA341. ModBase considers a MPQS > 1.1 to indicate a reliable structural model. The 
ModBase database is included to supplement the Protein Data Bank and improve coverage of 
proteins without experimentally derived protein structures to over 17,000 distinct human 
proteins. 
 
Genetic Variation Databases 
 
The Exome Aggregation Consortium (ExAC) 
Whole-exome sequencing provides a comprehensive view of protein-coding variation within the 
human genome. To elucidate the mechanisms behind disease-causing variation, we must first 
understand the patterns of the neutral variation we all carry in abundance. ExAC aggregates 
whole-exome sequencing data from fourteen cohorts totaling 60,706 individuals and six human 
continental populations: African/African American, Latino, East Asian, South Asian, Finnish, 
and Non-Finnish European. This resource provides a high-resolution view of where putatively 
neutral variation is tolerated within human proteins and serves as a neutral background for the 
analysis of pathogenic missense variation. 
 
ClinVar 
Managed by the National Center for Bioinformatics (NCBI), ClinVar is a submission-based 
database of variant-disease associations. Clinical significance is assigned in accordance with 
recommendations by the American College of Medical Genetics (ACMG), which stratifies 
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variant disease associations into five classes: uncertain significance, benign, likely benign, likely 
pathogenic, and pathogenic. ClinVar represents our current understanding of the genetic cause of 
many complex diseases, but also includes Mendelian associations reported by the Online 
Mendelian Inheritance in Man (OMIM). 
 
Linking Genetic Variants to Protein Structure 
 
There are three primary components required to link genetic and protein structural information. 
The first involves the reconciliation of protein structural sequences with reference protein 
sequences and alignment with the human genome. The second is consequence determination for 
protein-coding genetic variants. Third, these two sources must be joined using shared identifiers 
to create a complete path from genetics to protein structure, enabling high-throughput analyses. 
A schematic of the PDBMap pipeline and database is provided for reference in Figure 1. 
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 Figure 2: A schematic overview of the PDBMap pipeline and database. Structural processing tasks are shown in blue. Alignment of protein chains with gene transcripts is shown in red. Consequence prediction for genetic variation is shown in green. Intersection of genetic datasets with the structure-to-genome mapping is shown in purple. Light blue and orange describe downstream applications of this resource. Dashed arrows indicate where external data is fed into the pipeline. 
 
Aligning protein structures to the human genome 
A protein structure is a snapshot of the three-dimensional conformation assumed by a human 
protein. However, the experimental process of deriving these structures is a source of both 
intentional (e.g. expression tags, mutations) and incidental (e.g. alternative residue numbering) 
deviations from the reference protein sequence. In many cases, these errors can be resolved 
through simple pairwise alignment, but recently a more robust alternative was released. SIFTS41 
is a manually curated database of protein structural information that, among other useful 
annotations, provides a residue-level mapping from structure to reference sequence for each 
amino acid in a protein. Further, protein sequences not matching the reference sequence (e.g. 
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expression tags, mutations) can be easily identified and/or removed. Any remaining alignment 
errors are corrected through simple pairwise alignment.  
Having aligned each chain of each protein structure to its reference protein sequence 
(structome to proteome), we next attempt to match UniProt proteins with EnsEMBL gene 
transcripts (proteome to genome). For each protein accession identifier, UniProt provides a list of 
corresponding EnsEMBL gene transcripts. However, the two databases often disagree, primarily 
due to differences in the handling of genes with multiple isoforms and homologous genes that 
produce highly similar transcripts. This issue is compounded by the lack of protein isoform 
information in the PDB. This introduces a many-to-many relationship between gene transcripts 
and protein isoforms, where not all transcript-isoform matches are valid. We again approach this 
step as an alignment problem. Rather than aligning protein structure sequences to reference 
protein sequences, we instead align them directly to the translated peptide sequences of 
EnsEMBL gene transcripts. Alignments with high sequence identity (>90% with respect to 
protein structure) are considered valid matches (not only does the protein identifier match, but 
the specific protein isoform matches the sequence encoded by the gene transcript). This approach 
identifies and removes transcripts that could not plausibly produce the sequence observed in the 
protein structure. The 90% threshold is intended to accommodate minor alterations to the protein 
sequence, like point mutations or short gaps in the protein structure.  
Using the aligned EnsEMBL transcripts for each protein structure, we derive the nucleotide 
coordinates for each amino acid in the protein sequence. On completion of this pipeline, every 
amino acid in every protein structure is directly annotated with both its structural and genomic 
coordinates. Of the 20,160 human proteins reviewed by Swiss-Prot, PDBMap currently includes 
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27,624 protein structures containing 5,223 (26%) distinct human proteins and 102,235 homology 
models containing 17,341 (86%) distinct human proteins.  
 
Determining variant consequence 
Not all protein-coding variants cause a change in the protein sequence. Some may introduce 
stop-codons that truncate the protein, while some nucleotide substitutions produce codons that 
encode the same amino acid. Similarly, a single variant may have different consequences or 
affect different amino acid positions for different gene transcripts. We determine variant 
consequences using EnsEMBL’s Variant Effect Predictor (VEP)42 tool. In addition to 
determining transcript-specific consequences for each genetic variant, VEP also provides 
numerous informative annotations including global and population allele frequencies, gene and 
transcript annotations, and pathogenicity predictions from established tools like SIFT and 
PolyPhen2. None of the information reported by VEP is required for structural mapping (only 
the genomic position is required), but consequence prediction is useful for validation and critical 
for understanding the potential effects of each variant on the protein structure. 
 
Intersecting genetics and structure 
We’ve presented above the structural and genetic components of the PDBMap database. The first 
provides a direct link between the structural and genomic coordinates of each amino acid in a 
protein structure. The second determines the consequence of each genetic variant for each 
transcript of the affected gene. Both datasets now contain a collection of shared identifiers that 
we can use to efficiently map all genetic variants into protein structure. This alignment is 
conducted in two stages. 
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To create the initial mapping from genetic variant to protein structure, we generate two sets 
of genomic coordinates. The first is the set of genomic ranges that define the codon for each 
amino acid in a protein structure. The second is a set of genomic positions (or ranges, if INDELS 
are present) identifying the location of each genetic variant. Using intersectBED43, we can 
efficiently intersect these two datasets to identify all variant positions that overlap codons 
mapped to amino acids in a protein structure, in effect mapping genetic variants into protein 
structure. We then use the consequence predictions from VEP to eliminate matches where the 
transcript associated with the variant consequence does not match the transcript aligned to the 
protein sequence. Finally, we verify that the affected protein position predicted by VEP matches 
the reference position in the matched protein structure. These final two steps use information 
derived from different sources to eliminate erroneous mappings. Upon completion of the 
intersection and validation, a direct link is created between each genetic variant and each amino 
acid in every protein structure affected by that variant. The current status of genetic datasets in 
the PDBMap database is provided in Table 1. 
 
 Total  Mapped to PDB Mapped to ModBase 
ExAC Synonymous 1,549,333 178,626 (12%) 955,173 (62%) 
ExAC Missense 2,971,797 300,604 (10%) 1,809,201 (61%) 
ClinVar Missense 56,162 13,997 (25%) 38,894 (69%) 
COSMIC Missense 1,366,383 158,985 (12%) 881,446 (65%) Table 1: Number of distinct synonymous or missense variants within each genetic dataset. 
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High-throughput analysis of genetic variation in protein structure 
The alignment of a large whole-exome sequencing dataset with all protein structures in the 
Protein Data Bank and/or ModBase is a complicated and time-consuming task. Running the 
described pipeline for a dataset like ExAC, parallelized across chromosomes, requires just over a 
day of processing time. However once the process is complete and the results uploaded to the 
PDBMap database, the coordinates of any variant or set of variants in any or all affected protein 
structures can be rapidly determined with a simple MySQL query. For example, querying the 
structural coordinates of all ExAC synonymous and missense variants in all solved protein 
structures requires just over one second of processing (plus download time).  
 
Conclusion 
 
This resource enables high-throughput, large-scale analysis of protein-coding variation within 
protein structures. In the following chapters, we present several spatial analyses comparing 
different classifications of protein-coding, single-nucleotide variation. All of the work included 
in those chapters is derived from and dependent upon the structure-to-genome mapping provided 
by the PDBMap database. 
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CHAPTER III 
 
QUANTIFYING SPATIAL PATTERNS OF GERMLINE PROTEIN-CODING  
VARIATION IN PROTEIN STRUCTURES 
 
Introduction 
 
The foundational work presented in Chapter II facilitates efficient, large-scale analysis of 
missense variation in its protein structural context. As described in Chapter I, several approaches 
have been used in the analysis of somatic mutations in cancer. These analyses have largely been 
focused towards specific hypotheses and the re-identification of canonical examples from cancer. 
In this chapter, we present a general, statistical framework – adapted from Ripley’s K44–46 – for 
defining and evaluating the spatial distribution of missense variants (and other residue-level 
annotations) in protein structures. We focus the application of this methodology towards the 
analysis of evolutionary conservation and germline variation. We first evaluate the fundamental 
hypothesis that missense variants are spatially constrained and that this constraint is not observed 
in synonymous variation. We next determine if the clustering of evolutionarily conserved amino 
acids is a general phenomenon. Finally, we evaluate the spatial distributions of disease-causing 
missense variation, contrast it with neutral variation, and evaluate the predictive performance of 
these spatial relationships. 
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Methods 
 
Protein structure selection, variant mapping, and annotation 
Three single-nucleotide variant (SNV) datasets were included in our comprehensive analyses: 
Exome Aggregation Consortium35 (ExAC) r0.3, and ClinVar (01-07-2016). Synonymous SNVs 
in ExAC were included for comparison with ExAC missense SNVs. All other datasets were 
reduced to missense SNVs. Variant consequences and annotations were determined using v82 of 
the Ensembl Variant Effect Predictor.42 Additional dominant and recessive HGMD36 missense 
variants from Turner et al.23 were used to investigate gain- and loss-of-function spatial patterns. 
 Ensembl47 transcripts were matched with UniProt48 accession and Protein Data Bank37 
(PDB) IDs using ID-mapping tables provided by UniProt. Reference protein sequences were 
aligned with observed sequences in the PDB using SIFTS.41 Any discrepancies were corrected 
by pairwise alignment with Biopython.49 Proteins were represented by the subset of minimally 
overlapping PDB structures described by Kamburov et al.26. For each protein, the algorithm 
selects the PDB chain with the greatest coverage of the protein sequence. This process continues 
iteratively, excluding PDB chains with greater than 10% sequence overlap with the set of already 
selected chains, until the complete sequence is structurally represented or all available structures 
have been processed. Evolutionary conservation was calculated by Jensen-Shannon divergence50 
using multiple sequence alignments from HSSP51.  
 For each missense variant in ExAC, we identified the Euclidean nearest neighbor using 
genomic position and protein structural coordinates. Genomic nearest neighbors were restricted 
to other missense variants within the same gene. Structural distances were measured from the 
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centroid of each amino acid side-chain. Missense variants without a neighbor in either the gene 
or protein structure were excluded from the comparison. 
 
Ripley’s K for quantifying spatial distributions in protein structure 
Ripley’s K is a test for spatial heterogeneity that measures the deviation of a set of positions from 
complete spatial randomness (CSR), capturing both clustering and dispersion. Because missense 
variants are constrained to the positions of amino acids in a protein structure, the assumption of 
CSR for randomly distributed variants is inappropriate. In a constrained space, permutation 
testing provides an empirical null distribution for comparison with observed patterns. At each 
distance threshold, the number of neighbors around each variant is compared with the empirical 
null expectation. When the number of neighbors exceeds expectation, the variants are clustered; 
when the number of neighbors is lower than expectation, the variants are dispersed. Because K is 
measured across a range of distances, it is possible to identify clustering or dispersion at any 
scale. Our estimator for K is defined as, 
𝐾� =  ∑  ∑  𝐼(𝐷𝑖𝑖 < 𝑡)𝑁𝑖!=𝑖𝑁𝑖
𝑁(𝑁 − 1)  
where N is the number of variants, Dij is the Euclidean distance between variants i and j in the 
protein structure, and I is an indicator function that evaluates to 1 when Dij is less than the 
distance threshold t and 0 otherwise. N(N-1) is applied as a normalization factor such that K is 
the proportion of variant pairs within distance t. This normalization allows for comparison 
between proteins with different variant counts. Variant positions are defined as the centroid of 
the reference amino acid. Permutations are generated by randomly sampling N amino acids from 
the protein structure over 100,000 iterations and recomputing K. Two-tailed p-values are derived 
from the percentile rank of the observed K value relative to the distribution of permuted K 
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values. Z-scores are also calculated to indicate the direction (clustering or dispersion) and 
magnitude of the effect. An illustrative description of the K analysis is shown in Figure 1. 
 
 Figure 3: Quantifying the spatial distribution of missense variants in protein structure with Ripley’s K. (A) Missense variants are mapped into solved structures from the Protein Data Bank. (B) Using a range of distance thresholds, (C) the proportion of variants within that radius is measured. (D) An empirical null distribution is determined through random shuffling of variant positions (un-weighted univariate) or variant labels (bivariate and weighted univariate) and used to calculate permutation p-values. 
 
 Ripley’s K can also evaluate real-valued data to determine if the values are spatially 
correlated, conditioned on the variant positions. The weighted K is define as, 
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𝐾�𝑤𝑤𝑖𝑤ℎ𝑡𝑤𝑡 =  ∑  ∑  𝐼�𝐷𝑖𝑖 < 𝑡�𝑤𝑖𝑁𝑖!=𝑖𝑁𝑖 ∑  ∑  𝑤𝑖𝑁𝑖!=𝑖𝑁𝑖  
where wj is the weight applied to variant j. A variant cannot be counted as its own neighbor, so 
the weight of wi is not included in the function. The implication of this restriction is that a single, 
high-valued variant cannot form its own cluster. 
 The weighed K analyzes the process by which weights, not positions, are distributed. 
Thus, the significance of the weighted K is calculated by permuting weights over fixed positions 
and recomputing K. This approach assesses whether the assigned values are significantly 
clustered or dispersed beyond what is explained by variant position. When N is small, our ability 
to assess the significance of the weighted K is constrained by the number of unique permutations 
of the sample weights. 
 Ripley’s K is designed to quantify spatial distributions across a range of distances, 
capturing clustering or dispersion at any scale. To evaluate spatial patterns only at biologically 
relevant distance scales, we define the distance range from the minimum observed distance 
between variants to half the maximum observed distance between variants. Proteins for which 
the minimum distance was greater than half the maximum distance were extended to the 
maximum distance. 
 While the ability to investigate spatial patterns at multiple distances is valuable, a protein-
level summary statistic is required to compare between proteins and identify those containing 
significant spatial patterns. Each protein is summarized by the difference between observed K 
values and the median empirical null K values. The area between the curves is defined as the 
difference of their integrals, as estimated by Simpson’s rule. This summarization captures the 
direction (clustering or dispersion) and magnitude (absolute z-score) of the multi-distance signal 
observed for that protein. The distance threshold yielding the most significant signal is also 
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retained to approximate the scale at which the spatial signal is strongest. Finally, a protein 
summary z-score and p-value is determined by calculating the summary K for each permutation, 
such that positive z-scores indicate clustering, negative z-scores indicate dispersion, and z-scores 
near zero indicate spatial randomness (e.g. a lack of spatial constraint). To control for a False 
Discovery Rate of 10%, we calculate q-values from the protein-summary p-value distribution in 
each analysis. 
 
Bivariate K for spatial comparisons between variant datasets 
The univariate K is useful for quantifying biases in the spatial distribution of a single dataset, but 
many biological questions involve comparisons between variants of different types (e.g. neutral 
and deleterious). These comparisons are best made with bivariate K functions. The simplest form 
of the bivariate test examines whether one set of positions is more or less clustered than another 
using the difference in K between the two datasets. 
𝐷� =  𝐾�𝑁 −  𝐾�𝑀 
Similar to the weighted univariate K, the bivariate D45 evaluates the process by which dataset 
labels are assigned. It follows that the significance of the bivariate D is determined through 
random permutation of the class labels over fixed positions.  
 
Relative proximity to pathogenic variation as a predictor of pathogenicity 
To measure the proximity of an unlabeled variant to a set of known variants, the distance 
between each variant is first transformed by the NeighborWeight function52, 
NeighborWeight(x, y, lower bound, upper bound) = 
⎩
⎪
⎨
⎪
⎧
1, 𝑖𝑖 𝑑𝑥,𝑦 ≤ 𝑙𝑙𝑤𝑙𝑙 𝑏𝑙𝑏𝑏𝑑
1
2
�cos ( 𝑑𝑥,𝑦 − 𝑙𝑙𝑙𝑙𝑙 𝑏𝑙𝑏𝑏𝑑
𝑏𝑢𝑢𝑙𝑙 𝑏𝑙𝑏𝑏𝑑 − 𝑙𝑙𝑙𝑙𝑙 𝑏𝑙𝑏𝑏𝑑 × 𝜋)+1�,
𝑖𝑖 𝑙𝑙𝑤𝑙𝑙 𝑏𝑙𝑏𝑏𝑑 <  𝑑𝑥,𝑦 < 𝑏𝑢𝑢𝑙𝑙 𝑏𝑙𝑏𝑏𝑑0, 𝑖𝑖 𝑑𝑥,𝑦 ≥ 𝑏𝑢𝑢𝑙𝑙 𝑏𝑙𝑏𝑏𝑑  
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where 𝑑𝑥,𝑦 is the distance between variants x and y. A lower bound of 8Å provides full weight to 
amino acids for which direct interaction is plausible. A lower bound of 24Å centers the cosine 
curve on 16Å, providing larger weights to variants with the potential for indirect interaction and 
smaller weights to variants with some likelihood of affecting similar structural regions or 
domains. Using this transformation, we define the average proximity of an unlabeled variant x to 
a set of variants Y as, 
𝑃𝑥,𝑌 = �𝑁𝑙𝑖𝑁ℎ𝑙𝑙𝑜𝑙𝑖𝑁ℎ𝑡(𝑥,𝑦, 8,24)|𝑌|𝑌
𝑦
 
The pathogenic proximity score for each variant is then defined as the relative proximity to 
pathogenic and putatively neutral variation, 
∆𝑃𝑥 =  𝑃𝑥,𝑝𝑝𝑡ℎ𝑜𝑤𝑤𝑜𝑖𝑜 − 𝑃𝑥,𝑜𝑤𝑛𝑡𝑛𝑝𝑛 
such that values of ∆𝑃𝑥 greater than 0 indicate that variant x is more nearby pathogenic variants 
than neutral variants. Using leave-one-out cross validation, we rank variants by their relative 
proximity to ClinVar pathogenic and ExAC missense variants and calculate receiver-operator-
characteristic (ROC) and precision-recall (PR) curves. We evaluate predictive performance using 
area under ROC and PR curves (AUC). These results are then compared using Analysis of 
Variance (ANOVA) with pathogenicity predictions from PolyPhen2, SIFT, and evolutionary 
conservation. 
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Results 
 
Most SNVs have a different nearest neighbor in sequence and structure 
Nearly all analyses of protein-coding variation are based on the position of variants within the 
linear nucleotide or protein sequence. More recent analyses have begun grouping variants by 
gene53 or predicted functional domains54. These partitions are problematic for spatial analyses 
because protein folding dramatically alters the spatial distribution of amino acids, bringing 
linearly distant residues into close structural proximity. To assess the extent of this phenomenon, 
we examined each ExAC missense variant and identified its nearest neighboring missense 
variant by genomic and structural coordinates. We found that nearest neighbors differed between 
sequence and structure for 60% of structure-mapped missense variants. While this metric doesn’t 
quantify the full impact of protein folding on the spatial landscape of missense variation, it 
highlights the potential impact of incorporating structural information into spatially informed 
aggregate analyses of protein-coding variation like collapsing tests, burden tests, and SKAT55, 
which may not otherwise be capturing the most relevant functional groups of missense variants. 
 
Synonymous and missense variants have different spatial distributions 
An important assumption in our spatial analyses is that patterns of missense variation are 
influenced by the functional and structural impact of amino acid substitution. However, the 
spatial patterns we observe can also arise from other biological and technical effects, like 
inconsistencies in mutation rate, sequencing coverage, and similar effects. To test this 
assumption and evaluate the extent to which these effects influence the observed spatial 
distributions, we compared the spatial distributions of synonymous variants and missense 
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variants from ExAC. Synonymous variants do not alter protein sequence, so their distribution in 
protein structure should be under no spatial constraint. Thus, all deviations from spatial 
randomness can be attributed to the genomic inconsistencies that affect both synonymous and 
missense variation. By evaluating the spatial distribution of missense variants in protein structure 
in reference to the spatial distribution of synonymous variants, we can identify the patterns of 
spatial constraint attributable only to amino acid substitution. For each protein, we calculated the 
univariate K for synonymous and nonsynonymous variants. As expected, we find that 
synonymous variants show little divergence from random spatial distributions (Figure 2), with 
only one protein reaching statistical significance (MYOM1, FDR<0.1). Conversely, missense 
variants display a general trend towards spatial dispersion and were significantly non-randomly 
distributed in 51 proteins; 37 with significant dispersion and 14 with significant clustering (Table 
1). There was a highly significant difference between the synonymous (Nsynonymous=4,498) and 
missense (Nmissense=4,487) spatial distributions (p=2.71x10-120 Mann Whitney U), supporting the 
hypothesis that missense variants are under increased spatial constraint relative to synonymous 
variants. 
 Despite the difference in the univariate trends, a bivariate analysis directly comparing 
synonymous and missense variants in 4,173 proteins identified only two in which missense 
variants were significantly more dispersed than synonymous. These results suggest that while 
globally, missense variants are consistently more dispersed than synonymous variants, within 
any given protein structure the sample size is likely too small and the difference too subtle to 
reach significance. 
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 Figure 4: The distribution of protein-summary z-scores describes the general spatial patterns of a variant dataset. Synonymous variants from ExAC are generally randomly distributed, as indicated by a near-normal distribution of z-scores with median near 0. In contrast, missense variants from ExAC trend towards spatial dispersion, with significant spatial patterns identified for 51 proteins. 
 
Spatial dispersion identifies a tendency for protein surface residues 
In an unconstrained space, dispersion manifests as an even spacing between observations (Figure 
S1). Because protein structure is a constrained space, we hypothesized that dispersion would be 
greatest for amino acids at the protein surface. This is supported by a previously observed bias 
for population-derived missense variants to preferentially alter surface residues.56 We performed 
two analyses to investigate whether signals of spatial dispersion identified by the univariate K 
were correlated with surface exposure. 
 We first performed a weighted, univariate K analysis of relative solvent accessibility 
(RSA). If collections of surface-exposed residues yield high dispersion values, then RSA should 
yield highly significant dispersion across all structures. Indeed, we observed significant spatial 
dispersion in 4,114 of 4,495 proteins (92%, FDR<10%) (Figure 3). 
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 We next evaluated whether missense variants where more solvent accessible than all 
residues, which would indicate a bias for residues at the protein surface. We found that the RSA 
of all missense variants (Nall,missense=209,841) was significantly greater than the RSA of all 
residues (Nall,residue=972,121) (p≈0 Mann Whitney U) and that the RSA of missense variants in 
significantly dispersed missense variants (Ndispersed,missense=2,253) was significantly greater than 
the RSA of all missense variants (p= 5.0x10-54 Mann Whitney U). Interestingly, we also found 
that significantly clustered missense variants (Nclustered,missense=428) were no more or less solvent 
accessible than all residues (Nclustered,residue=2,902) (p=0.39 Mann Whitney U), suggesting that 
clusters of missense variants affect both the protein core and surface. 
 
 Figure 5: Distribution of protein z-scores for the weighted univariate analysis of relative solvent accessibility (RSA). The significant dispersion of RSA in 92% of proteins demonstrates that spatial dispersion identifies a bias for surface residues. 
 
Evolutionary conservation is spatially constrained and generally clustered 
As we currently lack a comprehensive understanding of the molecular function of all proteins in 
our study, evolutionary conservation serves as the most uniform measure of functional 
importance. Previous studies have demonstrated on a small scale that conserved residues form 
spatial clusters in protein structure5 and that minimizing the distance between conserved residues 
can improve structure prediction7. Considering the conservation of sequence-adjacent residues 
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has also been shown to improve the identification of functionally important protein residues50. 
To evaluate the tendency for evolutionarily conserved residues to cluster in protein structure, we 
performed a weighted, univariate K analysis of evolutionary conservation scores. We identified 
significant clustering in 3,752 of 4,286 proteins (88%, FDR<0.1) and significant dispersion in 
101 proteins (2%). (Figure 4). This finding confirms that clustering of evolutionarily conserved 
residues is a general phenomenon. Furthermore, it forms the basis for our analysis of pathogenic 
variation in protein structure, as it demonstrates that protein function – as measured by 
evolutionary conservation – is spatially constrained and detectable with our methodology. By 
directly analyzing pathogenic variants, we can determine which of these regions are most 
relevant to particular diseases and identify regions poorly suited to evolutionary analysis, like 
gain-of-function hotspots. 
 
 Figure 6: Distribution of protein z-scores for the weighted univariate analysis of evolutionary conservation as measured by Jenson-Shannon divergence. Evolutionary conservation is significantly clustered in 88% of protein structures. 
 
Pathogenic missense variants are spatially clustered within protein structures 
Pathogenic missense variants derive their pathogenicity from the disruption of protein structure 
and function. We have demonstrated that functional residues commonly form clusters in protein 
structure, thus we expect pathogenic variants to form clusters at functional sites relevant to 
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specific diseases. We analyzed 449 protein structures containing three or more pathogenic 
variants from ClinVar and identified a global trend towards clustering (Figure 5), with significant 
clustering of pathogenic variants in 125 proteins (22%) and significant dispersion in one protein. 
To determine if these clusters were characteristic of pathogenic variation – and not spatial 
constraints on missense variation – we performed a bivariate analysis of pathogenic variants 
relative to putatively neutral missense variants from ExAC in 440 proteins containing three or 
more variants from each set. We identified 112 proteins (25%) in which ClinVar pathogenic 
variants were significantly more clustered than ExAC missense variants, 98 of which were also 
significant in the univariate analysis (Figure 6). This union represents proteins in which the 
clustering of ClinVar pathogenic variants is statistically significant and independent from the 
general patterns observed for missense variation, suggesting that pathogenic variants have focal 
effects within a protein structure. 
 
 Figure 7: Distribution of z-scores for the un-weighted univariate analysis of ClinVar pathogenic missense variants. Pathogenic variants demonstrate a strong trend towards spatial clustering, with significant clustering identified in 126 proteins (28%). 
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 Figure 8: Comparison of the univariate and bivariate p-values for ClinVar pathogenic variation. The dashed lines mark the p-value threshold from each analysis where q<0.1. Proteins plotted in orange were significantly clustered in only one analysis. Proteins plotted in red had significant clustering of ClinVar pathogenic variants that exceeded what was observed for ExAC missense variants. 
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Dominant missense variants form smaller clusters than recessive variants 
Having demonstrated pathogenic variants trend towards spatial clustering, we next evaluated 
whether the mode of inheritance for pathogenic variants influences their spatial constraint. 
Missense variants causing protein loss-of-function (LoF) may disrupt numerous critical elements 
of a protein structure, but the opportunity for gain-of-function (GoF) is likely limited to a small 
subset of regions with functional potential. Previous work by Turner et al.23 investigated these 
spatial patterns in protein sequence using autosomal dominant (AD, typically gain-of-function) 
and autosomal recessive (AR, typically loss-of-function) missense variants from the Human 
Gene Mutation Database36 (HGMD). Turner et al. demonstrated a significant global trend for 
dominant variants to be more clustered than recessive, which in turn were more clustered than 
neutral variants from the 1000 Genomes Project, with dominant variants in 9 proteins and 
recessive variants in 5 proteins significantly more clustered than neutral variants (FDR<5%). 
 The functional impact of gain- and loss-of-function missense variants is derived from 
their effect on protein structure. Thus, the spatial distributions derived from these effects are 
perhaps more accurately evaluated within that context. Using the HGMD dataset curated by 
Turner et al., we performed two bivariate analyses evaluating dominant and recessive missense 
variants relative to ExAC missense variants (Figure 7). We identified 27 (of 69, 39%) and 16 (of 
47, 34%) structures in which dominant and recessive variants (respectively) were significantly 
more clustered than variants from ExAC (FDR<10%). Additionally, we found that univariate 
scores for both dominant and recessive variants were significantly higher (more clustered) than 
ExAC variants (AD: p=3.53x10-30, AR: p=6.97x10-20 Mann Whitney U), but found no significant 
difference between dominant and recessive variants (p=0.274). However, within proteins with 
significantly clustered variation, dominant variants (NAD=35) formed significantly smaller 
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clusters (median peak significance: 10Å) than recessive variants (NAR=16) (median peak 
significance: 13.5Å) (p=0.014 Mann Whitney U). These findings support previous conclusions 
that both gain- and loss-of-function variants are more clustered than neutral variants. The smaller 
clusters formed by dominant variants additionally support the hypothesis that gain-of-function 
mutations are localized to specific sites with functional potential, while loss-of-function 
mutations more generally disrupt regions of functional importance. 
 Figure 9: Autosomal dominant and recessive missense variants from the Human Gene Mutation Database (HGMD) are both spatially more clustered than ExAC missense variants in protein structure, consistent with ClinVar pathogenic variation. No significant difference in the strength of clustering was identified between the two groups, but dominant mutations did on average form smaller clusters (AD=11Å, AR=14Å). 
 
Proximity to clustered pathogenic variants is predictive of pathogenicity 
The identification of pathogenic variant clusters in protein structures may lead to better 
understandings of disease etiology and improvements in pathogenicity prediction for variants of 
unknown significance. To estimate the predictive potential of spatial information, we defined a 
simple metric that ranks amino acids by their relative proximity to pathogenic and neutral 
variation and measures predictive performance using leave-one-out cross validation (Figure 8). 
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Applying this approach to all 442 proteins from the bivariate analysis of ClinVar pathogenic and 
ExAC missense variants did not accurately classify pathogenic and neutral variants (median 
ROC AUC=0.55), but performance on the subset of 98 proteins with significant univariate and 
bivariate clustering of pathogenic variants was significantly improved (median ROC AUC=0.73, 
p=2.46x10-17 Mann Whitney U) and comparable to SIFT, PolyPhen2, and evolutionary 
conservation (ANOVA p=0.128) (Figure 9). To determine if protein fold or conformation 
influenced the performance of spatial proximity, we stratified our analysis by CATH domain. 
We observed no significant difference in performance between protein structures containing the 
various CATH domains (Figure 10). These results suggest that proximity to pathogenic clusters, 
not individual pathogenic variants, is predictive of variant pathogenicity. 
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 Figure 10: The average proximity of each residue to missense variants in the (A) neutral and (B) pathogenic datasets is measured using the NeighborWeight function. Residues are then scored by (C) the difference in their pathogenic and neutral proximity scores. Prediction performance is then quantified using the area under the (D) receiver-operating characteristic curve (ROC AUC). 
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 Figure 11: Receiver-operating characteristic (ROC) curves for spatial prediction performance. (A) Predictive performance over all proteins is poor, but (B) for proteins in which ClinVar pathogenic variants are significantly more clustered than ExAC missense variants, spatial prediction performance is comparable (ANOVA p=0.46) to general pathogenicity prediction algorithms. 
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 Figure 12: Spatial prediction performance stratified by CATH domain. There were no significant differences in prediction performance between CATH domains (ANOVA p=0.28). 
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CHAPTER IV 
 
DISCUSSION 
 
The near-random spatial distributions of synonymous variation, in contrast with the trend 
towards spatial dispersion observed for missense variants, suggests that non-random spatial 
patterns of missense variation are derived from the functional effects (or lack thereof) of amino 
acid substitutions. Pathogenic variants are often significantly clustered in protein structure and 
are typically more clustered than neutral missense variants, with dominant variants forming 
smaller, more localized clusters than recessive variants. In proteins where pathogenic variants are 
significantly clustered and significantly more clustered than neutral variants, simple spatial 
predictors perform as well as general predictors of variant pathogenicity. 
 The spatial clustering of evolutionarily conserved amino acids in protein structures has 
been shown previously in only a small number of proteins. Our analysis evaluated all proteins 
with solved structures and confirmed the trend on a large scale. This property of conserved 
residues supports the hypothesis that deleterious variants, which are presumed to disrupt or 
enhance protein function, will also form spatial clusters.  
 Within most proteins, the difference between the spatial distributions of synonymous and 
missense variants distributions is subtle. However, comprehensive analysis of all proteins with 
solved structures reveals a significant shift towards missense variant dispersion, while 
synonymous variants vary little from spatial randomness. This shift towards dispersion and the 
significantly non-random spatial distributions of missense variants in 51 proteins suggest that the 
neutral and deleterious effects of amino acid substitutions influence the spatial constraint we 
 43 
observe for missense variation. It follows that we can infer from these distributions which 
regions of a protein are variant-intolerant. For proteins with significantly dispersed missense 
variation, we infer that variation in the core of the protein, likely affecting protein stability, is not 
well tolerated. Similarly, proteins with significant clustering of missense variants are variant-
intolerant in general, but contain isolated regions where mutations can be introduced without 
deleterious effects. 
 While conservation analysis provides a hypothesis about which regions of a protein are 
evolutionarily important and vulnerable to disruption, clusters of pathogenic variants identify 
regions with relevance to human disease. Pathogenic gain-of-function variant clustering may also 
identify regions with functional potential not captured by evolutionary analysis. We find that 
pathogenic missense variants were significantly clustered in 28% of the analyzed proteins. 
Comparison with the neutral missense background further improves our ability to identify 
pathogenic clustering that exceeds neutral expectation, while simultaneously filtering proteins in 
which the observed pathogenic clustering is attributable to general patterns of missense variation. 
In total, 99 proteins were found to contain significant clustering of pathogenic missense variants 
that significantly exceeded what was observed for neutral missense variants. 
 Separately analyzing dominant and recessive variants demonstrates that this phenomenon 
is not limited to gain- or loss-of-function. The tendency for dominant variants to form smaller 
clusters supports previous findings and suggests that gain-of-function potential is limited to a 
small number of residues, while loss-of-function variants affect larger regions of existing 
functional importance. These differences may assist in the classification of variants of unknown 
significance by setting an expectation for the distance between disease-causing variants in a 
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protein. Candidate variants within a plausible distance of a pathogenic cluster may be prioritized 
over more distant variants. 
 In the presence of pathogenic clustering, spatial proximity has the potential to enhance 
variant pathogenicity prediction. Clusters of pathogenic variation indicate regions of a protein 
structure that are functional, intolerant to variation, and contributory to disease. When attempting 
to classify variants of unknown significance, variants in close proximity to such a cluster are 
more likely to perturb functional and thus have a higher likelihood of causing a similar, 
deleterious effect. The limitation of this approach to variants with significantly clustered 
pathogenic variation may be due to small samples of known, pathogenic variants, but is likely 
exacerbated by a lack of specificity when relying exclusively on spatial information. The 
inclusion of evolutionary and biochemical features is essential to properly assessing the potential 
effect of an amino acid substitution. 
 To comprehensively investigate spatial patterns of genetic variation, we have 
summarized the multi-distance results for each protein by calculating the area between expected 
and observed K values. This approach captures robust signals identifiable over many distances. 
Other summarization approaches may capture different spatial patterns or reveal signals that are 
significant only at very specific distance scales. Ultimately, the utility of our multi-distance 
approach is the fine-grained analysis of individual protein structures, such that the details of 
these patterns are apparent. For an individual protein-of-interest, we recommend a review of the 
multi-distance results to identify the patterns most relevant to a specific hypothesis. Further, we 
have analyzed only a representative subset of proteins with solved structures in the Protein Data 
Bank, but selecting a structure in a relevant conformation is critical for the meaningful 
interpretation of spatial patterns within that protein. 
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 We have demonstrated in this study that evolutionarily conserved residues are almost 
universally clustered in protein structures, that missense variants are generally dispersed, that 
pathogenic variants are generally (and often significantly) clustered, and that differences between 
these distributions have the potential to predict variant pathogenicity. The methods we have 
proposed identify patterns in spatial data that are analogous to the input parameters required by 
many density-based and hierarchical clustering algorithms. Using data-driven parameterization 
of these algorithms, we can accurately define spatial boundaries for evolutionarily conserved, 
disease-associated, or variant-intolerant regions of protein structures. We have also started 
developing novel variant-aggregation and association methods that incorporate the spatial 
relationships identified in this study. In combination with the wealth of phenotypic data in 
electronic health records, which are becoming increasingly accessible for research, these 
approaches have the potential to associate specific protein regions directly with clinical 
outcomes. This thesis makes a significant advance in our understanding the spatial distribution of 
missense variants in protein structures that will ultimately improve our understanding of the link 
between protein structure, function, and human disease. 
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